What is CardioFocus?
CardioFocus is a specialized medical device manufacturer at the forefront of electrophysiology innovation. The company focuses on the development and commercialization of advanced pulsed field ablation technology, providing electrophysiologists with sophisticated catheters and generators designed to treat atrial fibrillation. By integrating these therapy platforms, CardioFocus aims to streamline clinical workflows and enhance patient outcomes. The firm occupies a critical niche in the healthcare landscape, bridging the gap between complex cardiac diagnostics and precise, efficient surgical intervention.
How much funding has CardioFocus raised?
CardioFocus has raised a total of $235.3M across 16 funding rounds:
Multiple Rounds
$49.2M
Multiple Rounds
$36.3M
Private Equity
$8M
Private Equity
$20.2M
Debt
$21M
Unspecified
$55M
Debt
$1M
Private Equity (2011): $13.6M, investors not publicly disclosed
Unspecified (2011): $30.6M led by KBL Healthcare Ventures, The Aurora Funds, Inc., Oxford Bioscience Partners, Fletcher Spaght Ventures, Manatuck Hill Partners, First Alliance & Capital Invest, Accuitive Medical Ventures, H.I.G. Capital, and SV Life Sciences
Debt (2011): $5M supported by Silicon Valley Bank
Debt (2014): $2.4M featuring Oxford Bioscience Partners, The Aurora Funds, Accuitive Medical Ventures, H.I.G. Capital, SV Life Sciences, and Fletcher Spaght Ventures, LP
Debt (2014): $2.3M backed by Allied Minds, Aurora Funds, Accuitive Medical Ventures, S.V. Life Sciences, and KBL Healthcare Ventures
Private Equity (2014): $31.7M with participation from Allied Minds, Aurora Funds, Accuitive Medical Ventures, S.V. Life Sciences, KBL Healthcare Ventures, and H.I.G.. BioVentures
Private Equity (2016): $8M led by Allied Minds, Aurora Funds, Accuitive Medical Ventures, S.V. Life Sciences, H.I.G. BioVentures, and KBL Healthcare Ventures
Private Equity (2017): $20.2M, investors not publicly disclosed
Debt (2018): $21M featuring GPB Capital
Unspecified (2019): $55M backed by Kennedy Lewis Investment Management
Debt (2020): $1M with participation from PPP
Key Investors in CardioFocus
H.I.G. Capital
A global alternative investment firm providing debt and equity capital to middle-market companies with a strong focus on healthcare and operational growth.
SV Health Investors
A specialist investment firm dedicated to backing innovative healthcare and life science companies through active support and sector-specific expertise.
Accuitive Medical Ventures
A market-driven venture capital firm specializing in revolutionary medical device technology and long-term value creation for healthcare stakeholders.
What's next for CardioFocus?
Following this major strategic investment, CardioFocus is well-positioned to accelerate the adoption of its pulsed field ablation platforms. The company's historical reliance on a diverse syndicate of venture capital and private equity partners suggests a mature operational strategy focused on scaling its product portfolio. Future initiatives will likely prioritize the expansion of its clinical footprint and the refinement of its integrated therapy systems to meet the growing demand for minimally invasive cardiac procedures. As the company continues to leverage its intellectual property and clinical partnerships, it remains a key player in the evolution of modern electrophysiology.
See full CardioFocus company page
